| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Tissue-specific transcriptome analyses provide new insights into GPCR signalling in adult Schistosoma mansoni | Hahnel, S Wheeler, N Lu, Z Wangwiwatsin, A McVeigh, P Maule, A Berriman, M Day, T Ribeiro, P Grevelding, CG |
2018 | ||||
| 2. | Epitope Mapping of Exposed Tegument and Alimentary Tract Proteins Identifies Putative Antigenic Targets of the Attenuated Schistosome Vaccine. | Farias, LP Vance, GM Coulson, PS Vitoriano-Souza, J Neto, APDS Wangwiwatsin, A Neves, LX Castro-Borges, W McNicholas, S Wilson, KS Leite, LCC Wilson, RA |
2020 | ||||
| 3. | Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a. | Joonlasak, K Batty, EM Kochakarn, T Panthan, B Kümpornsin, K Jiaranai, P Wangwiwatsin, A Huang, A Kotanan, N Jaru-Ampornpan, P Manasatienkij, W Watthanachockchai, T Rakmanee, K Jones, AR Fernandez, S Sensorn, I Sungkanuparph, S Pasomsub, E Klungthong, C Chookajorn, T Chantratita, W |
2020 | ||||
| 4. | Transcriptome of the parasitic flatworm Schistosoma mansoni during intra-mammalian development | Wangwiwatsin, A. Protasio, A.V. Wilson, S.E. |
2020 | ||||
| 5. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits. | Klanrit, P. Hanboonsong, Y. Yordpratum, U. Suksawat, M. Sermswan, R.W. Namwat, N. Loilome, W. Khampitak, T. Wangwiwatsin, A. Phetcharaburanin, J. |
2021 | ||||
| 6. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Thanee, M. Dokduang, H. Phetcharaburanin, J. Klanrit, P. Titapun, A. Namwat, N. Khuntikeo, N. Wangwiwatsin, A. Saya, H. Loilome, W. |
2021 | ||||
| 7. | Epitope Mapping of Exposed Tegument and Alimentary Tract Proteins Identifies Putative Antigenic Targets of the Attenuated Schistosome Vaccine | Wangwiwatsin, A. | 2021 | ||||
| 8. | Exposure to dexamethasone modifies transcriptomic responses of free-living stages of Strongyloides stercoralis | Rutchanee Rodpai Oranuch Sanpool Tongjit Thanchomnang Pokkamol Laoraksawong Lakkhana Sadaow Patcharaporn Boonroumkaew Arporn Wangwiwatsin Chaisiri Wongkham Porntip Laummaunwai Wannaporn Ittiprasert Paul J. Brindley Pewpan M. Intapan Wanchai Maleewong |
2021 | ||||
| 9. | Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a | Wangwiwatsin, A. Manasatienkij, W. Sensorn, I. Sungkanuparph, S. Pasomsub, E. Chantràtita, W. |
2021 | ||||
| 10. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma. | Sureerat Padthaisong Jutarop Phetcharaburanin Poramate Klanrit Jia Li Nisana Namwat Narong Khuntikeo Attapol Titapun Apiwat Jarearnrat Arporn Wangwiwatsin Panupong Mahalapbutr Watcharin Loilome |
2021 | ||||
| 11. | Investigating the microbiota of fermented fish products (Pla-ra) from different communities of northeastern Thailand | Rutchanee Rodpai Oranuch Sanpool Tongjit Thanchomnang Arporn Wangwiwatsin Lakkhana Sadaow Weeraya Phupiewkham Patcharaporn Boonroumkaew Pewpan M. Intapan Wanchai Maleewong |
2021 | ||||
| 12. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Kittirat, Y Phetcharaburanin, J Promraksa, B Kulthawatsiri, T Wangwiwatsin, A Klanrit, P Sangkhamanon, S Jarearnrat, A Thongchot, S Mahalapbutr, P Loilome, W Saya, H Namwat, N |
2021 | ||||
| 13. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models. | Malinee Thanee Sureerat Padthaisong Manida Suksawat Hasaya Dokduang Jutarop Phetcharaburanin Poramate Klanrit Attapol Titapun Nisana Namwat Arporn Wangwiwatsin Prakasit Sa-ngiamwibool Narong Khuntikeo Hideyuki Saya Watcharin Loilome |
2021 | ||||
| 14. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression. | Jittima Tomacha Hasaya Dokduang Sureerat Padthaisong Nisana Namwat Poramate Klanrit Jutarop Phetcharaburanin Arporn Wangwiwatsin Tueanjit Khampitak Supinda Koonmee Attapol Titapun Apiwat Jarearnrat Narong Khuntikeo Watcharin Loilome |
2021 | ||||
| 15. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles. | Suksawat, M. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Jarearnrat, A. Sangkhamanon, S. Loilome, W. |
2022 | ||||
| 16. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma. | Kittirat, Y. Suksawat, M. Thongchot, S. Padthaisong, S. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Titapun, A. Loilome, W. Saya, H. Namwat, N. |
2022 | ||||
| 17. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. | Suksawat, M. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Techasen, A. Wangwiwatsin, A. Mahalapbutr, P. Loilome, W. |
2022 | ||||
| 18. | H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism. | Treeriya, R Ho, PN Titapun, A Klanrit, P Suksawat, M Kulthawatsiri, T Sirirattanakul, S Loilome, W Namwat, N Wangwiwatsin, A Chamadol, N Khuntikeo, N Phetcharaburanin, J |
2023 | ||||
| 19. | Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells. | Kulthawatsiri, T Kittirat, Y Phetcharaburanin, J Tomacha, J Promraksa, B Wangwiwatsin, A Klanrit, P Titapun, A Loilome, W Namwat, N |
2023 | ||||
| 20. | The Hallmarks of Liver Fluke Related Cholangiocarcinoma: Insight into Drug Target Possibility. | Loilome, W Namwat, N Jusakul, A Techasen, A Klanrit, P Phetcharaburanin, J Wangwiwatsin, A |
2023 | ||||
| 21. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models | Phukhum, P Phetcharaburanin, J Chaleekarn, K Kittirat, Y Kulthawatsiri, T Namwat, N Loilome, W Khuntikeo, N Titapun, A Wangwiwatsin, A Khampitak, T Suksawat, M Klanrit, P |
2023 | ||||
| 22. | Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and . | Wangwiwatsin, A Kulwong, S Phetcharaburanin, J Namwat, N Klanrit, P Loilome, W Maleewong, W Reid, AJ |
2023 | ||||
| 23. | Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and Wolbachia | Wangwiwatsin, A. Kulwong, S. Phetcharaburanin, J. Namwat, N. Klanrit, P. Loilome, W. Maleewong, W. Reid, A.J. |
2023 | ||||
| 24. | Improving postoperative survival in cholangiocarcinoma: development of surgical strategies with a screening program in the epidemic region. | Thanasukarn, V Srisuk, T Luvira, V Tipwaratorn, T Jareanrat, A Rattanarak, K Kraphunpongsakul, K Khuntikeo, N Chindaprasirt, J Sanlung, T Chamadol, N Koonmee, S Sa-Ngiamwibool, P Klanrit, P Wangwiwatsin, A Namwat, N Loilome, W Muangritdech, N Prajumwongs, P Watanabe, N Ebata, T Titapun, A |
2024 | ||||
| 25. | Characterization and identification of extrachromosomal circular DNA in cholangiocarcinoma. | Win, ZZ Dokduang, H Kulwong, S Loilome, W Namwat, N Phetcharaburanin, J Wongsurawat, T Jenjaroenpun, P Klanrit, P Wangwiwatsin, A |
2025 | ||||
| 26. | Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling. | Dokduang, H Jarernrat, A Titapun, A Sitthirak, S Padthaisong, S Kittirat, Y Sangkamanon, S Sa-Ngiamwibool, P Wangwiwatsin, A Klanrit, P Namwat, N Jusakul, A Murakami, Y Loilome, W |
2025 | ||||
| 27. | Development of ready-to-use microtiter plates for enhanced ELISA detection of Opisthorchis viverrini antigens in urine samples. | Taron, W Jamnongkan, W Kamjanlard, C Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Techasen, A Titapun, A Boonmars, T Laummaunwai, P Sithithaworn, P Ngeontae, W Loilome, W |
2025 | ||||
| 28. | Discovery of novel serum peptide biomarkers for cholangiocarcinoma recurrence through MALDI-TOF MS and LC-MS/MS peptidome analysis. | Thanasukarn, V Prajumwongs, P Muangritdech, N Loilome, W Namwat, N Klanrit, P Wangwiwatsin, A Charoenlappanit, S Jaresitthikunchai, J Roytrakul, S Titapun, A |
2025 | ||||
| 29. | Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinoma. | Prajumwongs, P Titapun, A Thanasukarn, V Jareanrat, A Khuntikeo, N Namwat, N Klanrit, P Wangwiwatsin, A Chindaprasirt, J Koonmee, S Sa-Ngiamwibool, P Muangritdech, N Roytrakul, S Loilome, W |
2025 | ||||
| 30. | Metabolomic analysis of bioactive compounds in dill ( L.) extracts. | Thanuma, J Phetcharaburanin, J Dokduang, H Loilome, W Klanrit, P Wangwiwatsin, A Namwat, N |
2025 | ||||
| 31. | Mitochondrial genomic alterations in cholangiocarcinoma cell lines. | Faipan, A Sitthirak, S Wangwiwatsin, A Namwat, N Klanrit, P Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Boulter, L Dokduang, H Loilome, W |
2025 | ||||
| 32. | Proteomic profiling reveals common and region-specific protein signatures underlying tumor heterogeneity in cholangiocarcinoma. | Sitthirak, S Roytrakul, S Wangwiwatsin, A Namwat, N Klanrit, P Dokduang, H Sa-Ngiamwibool, P Titapan, A Jareanrat, A Thanasukarn, V Khuntikeo, N Boulter, L Loilome, W |
2025 | ||||
| 33. | The genome sequence of the liver fluke (Poirier, 1886) Stiles & Hassall, 1896. | Wangwiwatsin, A Kulwong, S Phuyao, C Titapun, A Loilome, W Klanrit, P Namwat, N Sithithaworn, P Doyle, SR Berriman, M Crellen, T , , , , |
2025 | ||||
| 34. | Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma. | Sitthirak, S Wangwiwatsin, A Jusakul, A Namwat, N Klanrit, P Dokduang, H Sa-Ngiamwibool, P Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Teh, BT Boulter, L Murakami, Y Loilome, W |
2025 | Count | 15 | 31 | 11 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Tissue-specific transcriptome analyses provide new insights into GPCR signalling in adult Schistosoma mansoni | Wangwiwatsin, A. | 2018 |
PLoS Pathogens 1 (14), pp. |
||||||||
| 2. | Transcriptome of the parasitic flatworm schistosoma mansoni during intra-mammalian development | Wangwiwatsin, A. Protasio, A.V. Wilson, S.E. |
2020 |
PLoS Neglected Tropical Diseases 5 (14), pp. 1-25 |
||||||||
| 3. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits | Klanrit, P. Hanboonsong, Y. Yordpratum, U. Suksawat, M. Sermswan, R.W. Namwat, N. Loilome, W. Khampitak, T. Wangwiwatsin, A. Phetcharaburanin, J. |
2021 |
Scientific Reports 1 (11), pp. |
||||||||
| 4. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Thanee, M. Dokduang, H. Phetcharaburanin, J. Klanrit, P. Titapun, A. Namwat, N. Khuntikeo, N. Wangwiwatsin, A. Saya, H. Loilome, W. |
2021 |
PLoS ONE 3 March (16), pp. |
||||||||
| 5. | Epitope Mapping of Exposed Tegument and Alimentary Tract Proteins Identifies Putative Antigenic Targets of the Attenuated Schistosome Vaccine | Wangwiwatsin, A. | 2021 |
Frontiers in Immunology (11), pp. |
||||||||
| 6. | Exposure to dexamethasone modifies transcriptomic responses of free-living stages of Strongyloides stercoralis | Sanpool, O. Thanchomnang, T. Sadaow, L. Boonroumkaew, P. Wangwiwatsin, A. Wongkham, C. Laummaunwai, P. Intapan, P.M. Maleewong, W. |
2021 |
PLoS ONE 6 June (16), pp. |
||||||||
| 7. | Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a | Wangwiwatsin, A. Manasatienkij, W. Sensorn, I. Sungkanuparph, S. Pasomsub, E. Chantràtita, W. |
2021 |
Virus Research (292), pp. |
||||||||
| 8. | Investigating the microbiota of fermented fish products (Pla-ra) from different communities of northeastern Thailand | Sanpool, O. Thanchomnang, T. Wangwiwatsin, A. Sadaow, L. Phupiewkham, W. Intapan, P.M. Maleewong, W. |
2021 |
PLoS ONE 1 January (16), pp. |
||||||||
| 9. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Kittirat, Y. Phetcharaburanin, J. Promraksa, B. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Jarearnrat, A. Thongchot, S. Mahalapbutr, P. Loilome, W. Saya, H. Namwat, N. |
2021 |
Frontiers in Public Health (9), pp. |
||||||||
| 10. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Dokduang, H. Padthaisong, S. Namwat, N. Klanrit, P. Phetcharaburanin, J. Wangwiwatsin, A. Khampitak, T. Koonmee, S. Titapun, A. Khuntikeo, N. Loilome, W. |
2021 |
Frontiers in Pharmacology (12), pp. |
||||||||
| 11. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles | Suksawat, M. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Jarearnrat, A. Sangkhamanon, S. Loilome, W. |
2022 |
PeerJ (10), pp. |
||||||||
| 12. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma | Kittirat, Y. Suksawat, M. Thongchot, S. Padthaisong, S. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Titapun, A. Loilome, W. Saya, H. Namwat, N. |
2022 |
Frontiers in Pharmacology (13), pp. |
||||||||
| 13. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma | Suksawat, M. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Techasen, A. Wangwiwatsin, A. Mahalapbutr, P. Loilome, W. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 14. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models | Phukhum, P. Phetcharaburanin, J. Chaleekarn, K. Kittirat, Y. Kulthawatsiri, T. Namwat, N. Loilome, W. Khuntikeo, N. Titapun, A. Wangwiwatsin, A. Khampitak, T. Suksawat, M. Klanrit, P. |
2023 |
Scientific Reports 1 (13), pp. |
||||||||
| 15. | Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and Wolbachia | Wangwiwatsin, A. Kulwong, S. Phetcharaburanin, J. Namwat, N. Klanrit, P. Loilome, W. Maleewong, W. Reid, A.J. |
2023 |
Frontiers in Microbiology (14), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Tissue-specific transcriptome analyses provide new insights into GPCR signalling in adult Schistosoma mansoni. | Hahnel, S Wheeler, N Lu, Z Wangwiwatsin, A McVeigh, P Maule, A Berriman, M Day, T Ribeiro, P Grevelding, CG |
2018 |
PLoS pathogens 1 (14), pp. e1006718 |
|
| 2. | Transcriptome of the parasitic flatworm Schistosoma mansoni during intra-mammalian development. | Wangwiwatsin, A Protasio, AV Wilson, S Owusu, C Holroyd, NE Sanders, MJ Keane, J Doenhoff, MJ Rinaldi, G Berriman, M |
2020 |
PLoS neglected tropical diseases 5 (14), pp. e0007743 |
|
| 3. | Epitope Mapping of Exposed Tegument and Alimentary Tract Proteins Identifies Putative Antigenic Targets of the Attenuated Schistosome Vaccine. | Farias, LP Vance, GM Coulson, PS Vitoriano-Souza, J Neto, APDS Wangwiwatsin, A Neves, LX Castro-Borges, W McNicholas, S Wilson, KS Leite, LCC Wilson, RA |
2020 |
Frontiers in immunology (11), pp. 624613 |
|
| 4. | Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a. | Joonlasak, K Batty, EM Kochakarn, T Panthan, B Kümpornsin, K Jiaranai, P Wangwiwatsin, A Huang, A Kotanan, N Jaru-Ampornpan, P Manasatienkij, W Watthanachockchai, T Rakmanee, K Jones, AR Fernandez, S Sensorn, I Sungkanuparph, S Pasomsub, E Klungthong, C Chookajorn, T Chantratita, W |
2020 |
Virus research (), pp. 198233 |
|
| 5. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression. | Tomacha, J Dokduang, H Padthaisong, S Namwat, N Klanrit, P Phetcharaburanin, J Wangwiwatsin, A Khampitak, T Koonmee, S Titapun, A Jarearnrat, A Khuntikeo, N Loilome, W |
2021 |
Frontiers in pharmacology (12), pp. 696961 |
|
| 6. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction. | Kittirat, Y Phetcharaburanin, J Promraksa, B Kulthawatsiri, T Wangwiwatsin, A Klanrit, P Sangkhamanon, S Jarearnrat, A Thongchot, S Mahalapbutr, P Loilome, W Saya, H Namwat, N |
2021 |
Frontiers in public health (9), pp. 766455 |
|
| 7. | Exposure to dexamethasone modifies transcriptomic responses of free-living stages of Strongyloides stercoralis. | Rodpai, R Sanpool, O Thanchomnang, T Laoraksawong, P Sadaow, L Boonroumkaew, P Wangwiwatsin, A Wongkham, C Laummaunwai, P Ittiprasert, W Brindley, PJ Intapan, PM Maleewong, W |
2021 |
PloS one 6 (16), pp. e0253701 |
|
| 8. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma. | Padthaisong, S Phetcharaburanin, J Klanrit, P Li, JV Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Wangwiwatsin, A Mahalapbutr, P Loilome, W |
2021 |
Cancer & metabolism 1 (9), pp. 30 |
|
| 9. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits. | Ho, PN Klanrit, P Hanboonsong, Y Yordpratum, U Suksawat, M Kulthawatsiri, T Jirahiranpat, A Deewai, S Mackawan, P Sermswan, RW Namwat, N Loilome, W Khampitak, T Wangwiwatsin, A Phetcharaburanin, J |
2021 |
Scientific reports 1 (11), pp. 23316 |
|
| 10. | Investigating the microbiota of fermented fish products (Pla-ra) from different communities of northeastern Thailand. | Rodpai, R Sanpool, O Thanchomnang, T Wangwiwatsin, A Sadaow, L Phupiewkham, W Boonroumkaew, P Intapan, PM Maleewong, W |
2021 |
PloS one 1 (16), pp. e0245227 |
|
| 11. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models. | Thanee, M Padthaisong, S Suksawat, M Dokduang, H Phetcharaburanin, J Klanrit, P Titapun, A Namwat, N Wangwiwatsin, A Sa-Ngiamwibool, P Khuntikeo, N Saya, H Loilome, W |
2021 |
Cancer & metabolism 1 (9), pp. 11 |
|
| 12. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression. | Thanee, M Dokduang, H Kittirat, Y Phetcharaburanin, J Klanrit, P Titapun, A Namwat, N Khuntikeo, N Wangwiwatsin, A Saya, H Loilome, W |
2021 |
PloS one 3 (16), pp. e0245871 |
|
| 13. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma. | Kittirat, Y Suksawat, M Thongchot, S Padthaisong, S Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Sangkhamanon, S Titapun, A Loilome, W Saya, H Namwat, N |
2022 |
Frontiers in pharmacology (13), pp. 897368 |
|
| 14. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles. | Sitthirak, S Suksawat, M Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sangkhamanon, S Loilome, W |
2022 |
PeerJ (10), pp. e13876 |
|
| 15. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. | Suksawat, M Phetcharaburanin, J Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Vilayhong, V Sa-Ngiamwibool, P Techasen, A Wangwiwatsin, A Mahalapbutr, P Li, JV Loilome, W |
2022 |
Frontiers in public health (10), pp. 766023 |
|
| 16. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models. | Phukhum, P Phetcharaburanin, J Chaleekarn, K Kittirat, Y Kulthawatsiri, T Namwat, N Loilome, W Khuntikeo, N Titapun, A Wangwiwatsin, A Khampitak, T Suksawat, M Klanrit, P |
2023 |
Scientific reports 1 (13), pp. 3072 |
|
| 17. | H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism. | Treeriya, R Ho, PN Titapun, A Klanrit, P Suksawat, M Kulthawatsiri, T Sirirattanakul, S Loilome, W Namwat, N Wangwiwatsin, A Chamadol, N Khuntikeo, N Phetcharaburanin, J |
2023 |
PeerJ (11), pp. e15386 |
|
| 18. | The Hallmarks of Liver Fluke Related Cholangiocarcinoma: Insight into Drug Target Possibility. | Loilome, W Namwat, N Jusakul, A Techasen, A Klanrit, P Phetcharaburanin, J Wangwiwatsin, A |
2023 |
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer (219), pp. 53-90 |
|
| 19. | Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells. | Kulthawatsiri, T Kittirat, Y Phetcharaburanin, J Tomacha, J Promraksa, B Wangwiwatsin, A Klanrit, P Titapun, A Loilome, W Namwat, N |
2023 |
PeerJ (11), pp. e16512 |
|
| 20. | Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and . | Wangwiwatsin, A Kulwong, S Phetcharaburanin, J Namwat, N Klanrit, P Loilome, W Maleewong, W Reid, AJ |
2023 |
Frontiers in microbiology (14), pp. 1052352 |
|
| 21. | Improving postoperative survival in cholangiocarcinoma: development of surgical strategies with a screening program in the epidemic region. | Thanasukarn, V Srisuk, T Luvira, V Tipwaratorn, T Jareanrat, A Rattanarak, K Kraphunpongsakul, K Khuntikeo, N Chindaprasirt, J Sanlung, T Chamadol, N Koonmee, S Sa-Ngiamwibool, P Klanrit, P Wangwiwatsin, A Namwat, N Loilome, W Muangritdech, N Prajumwongs, P Watanabe, N Ebata, T Titapun, A |
2024 |
World journal of surgical oncology 1 (22), pp. 287 |
|
| 22. | Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma. | Sitthirak, S Wangwiwatsin, A Jusakul, A Namwat, N Klanrit, P Dokduang, H Sa-Ngiamwibool, P Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Teh, BT Boulter, L Murakami, Y Loilome, W |
2025 |
Scientific reports 1 (15), pp. 10886 |
|
| 23. | Proteomic profiling reveals common and region-specific protein signatures underlying tumor heterogeneity in cholangiocarcinoma. | Sitthirak, S Roytrakul, S Wangwiwatsin, A Namwat, N Klanrit, P Dokduang, H Sa-Ngiamwibool, P Titapan, A Jareanrat, A Thanasukarn, V Khuntikeo, N Boulter, L Loilome, W |
2025 |
Scientific reports 1 (15), pp. 17228 |
|
| 24. | Mitochondrial genomic alterations in cholangiocarcinoma cell lines. | Faipan, A Sitthirak, S Wangwiwatsin, A Namwat, N Klanrit, P Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Boulter, L Dokduang, H Loilome, W |
2025 |
PloS one 6 (20), pp. e0323844 |
|
| 25. | Development of ready-to-use microtiter plates for enhanced ELISA detection of Opisthorchis viverrini antigens in urine samples. | Taron, W Jamnongkan, W Kamjanlard, C Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Techasen, A Titapun, A Boonmars, T Laummaunwai, P Sithithaworn, P Ngeontae, W Loilome, W |
2025 |
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy (343), pp. 126589 |
|
| 26. | Metabolomic analysis of bioactive compounds in dill ( L.) extracts. | Thanuma, J Phetcharaburanin, J Dokduang, H Loilome, W Klanrit, P Wangwiwatsin, A Namwat, N |
2025 |
PeerJ (13), pp. e19567 |
|
| 27. | Discovery of novel serum peptide biomarkers for cholangiocarcinoma recurrence through MALDI-TOF MS and LC-MS/MS peptidome analysis. | Thanasukarn, V Prajumwongs, P Muangritdech, N Loilome, W Namwat, N Klanrit, P Wangwiwatsin, A Charoenlappanit, S Jaresitthikunchai, J Roytrakul, S Titapun, A |
2025 |
Scientific reports 1 (15), pp. 2582 |
|
| 28. | Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling. | Dokduang, H Jarernrat, A Titapun, A Sitthirak, S Padthaisong, S Kittirat, Y Sangkamanon, S Sa-Ngiamwibool, P Wangwiwatsin, A Klanrit, P Namwat, N Jusakul, A Murakami, Y Loilome, W |
2025 |
Anticancer research 2 (45), pp. 579-592 |
|
| 29. | The genome sequence of the liver fluke (Poirier, 1886) Stiles & Hassall, 1896. | Wangwiwatsin, A Kulwong, S Phuyao, C Titapun, A Loilome, W Klanrit, P Namwat, N Sithithaworn, P Doyle, SR Berriman, M Crellen, T , , , , |
2025 |
Wellcome open research (10), pp. 1 |
|
| 30. | Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinoma. | Prajumwongs, P Titapun, A Thanasukarn, V Jareanrat, A Khuntikeo, N Namwat, N Klanrit, P Wangwiwatsin, A Chindaprasirt, J Koonmee, S Sa-Ngiamwibool, P Muangritdech, N Roytrakul, S Loilome, W |
2025 |
Scientific reports 1 (15), pp. 12782 |
|
| 31. | Characterization and identification of extrachromosomal circular DNA in cholangiocarcinoma. | Win, ZZ Dokduang, H Kulwong, S Loilome, W Namwat, N Phetcharaburanin, J Wongsurawat, T Jenjaroenpun, P Klanrit, P Wangwiwatsin, A |
2025 |
PloS one 5 (20), pp. e0322173 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Tissue-specific transcriptome analyses provide new insights into GPCR signalling in adult Schistosoma mansoni | Steffen Hahnel Nic Wheeler Zhigang Lu Arporn Wangwiwatsin Paul McVeigh Aaron Maule Matthew Berriman Timothy Day Paula Ribeiro Christoph G. Grevelding |
2018 |
PLOS PATHOGENS 1.0 (14.0), pp. |
22 | 0 | 0 | 0 | 0 | 0 | 22 | |
| 2. | Transcriptome of the parasitic flatworm Schistosoma mansoni during intra-mammalian development | Arporn Wangwiwatsin Anna V. Protasio Shona Wilson Christian Owusu Nancy E. Holroyd Mandy J. Sanders Jacqueline Keane Mike J. Doenhoff Gabriel Rinaldi Matthew Berriman |
2020 |
PLOS NEGLECTED TROPICAL DISEASES 5.0 (14.0), pp. |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 3. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits | Phuc N. Ho Poramate Klanrit Yupa Hanboonsong Umaporn Yordpratum Manida Suksawat Thanaporn Kulthawatsiri Anyarin Jirahiranpat Suthicha Deewai Panya Mackawan Rasana W. Sermswan Nisana Namwat Watcharin Loilome Tueanjit Khampitak Arporn Wangwiwatsin Jutarop Phetcharaburanin |
2021 |
SCIENTIFIC REPORTS 1.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 4. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Malinee Thanee Hasaya Dokduang Yingpinyapat Kittirat Jutarop Phetcharaburanin Poramate Klanrit Attapol Titapun Nisana Namwat Narong Khuntikeo Arporn Wangwiwatsin Hideyuki Saya Watcharin Loilome |
2021 |
PLOS ONE 3.0 (16.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 5. | Exposure to dexamethasone modifies transcriptomic responses of free-living stages of Strongyloides stercoralis | Rutchanee Rodpai Oranuch Sanpool Tongjit Thanchomnang Pokkamol Laoraksawong Lakkhana Sadaow Patcharaporn Boonroumkaew Arporn Wangwiwatsin Chaisiri Wongkham Porntip Laummaunwai Wannaporn Ittiprasert Paul J. Brindley Pewpan M. Intapan Wanchai Maleewong |
2021 |
PLOS ONE 6.0 (16.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 6. | Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a | Khajohn Joonlasak Elizabeth M. Batty Theerarat Kochakarn Bhakbhoom Panthan Krittikorn Kumpornsin Poramate Jiaranai Arporn Wangwiwatsin Angkana Huang Namfon Kotanan Peera Jaru-Ampornpan Wudtichai Manasatienkij Treewat Watthanachockchai Kingkan Rakmanee Anthony R. Jones Stefan Fernandez Insee Sensorn Somnuek Sungkanuparph Ekawat Pasomsub Chonticha Klungthong Thanat Chookajorn Wasun Chantratita |
2021 |
VIRUS RESEARCH (292.0), pp. |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 7. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma | Sureerat Padthaisong Jutarop Phetcharaburanin Poramate Klanrit Jia Li Nisana Namwat Narong Khuntikeo Attapol Titapun Apiwat Jarearnrat Arporn Wangwiwatsin Panupong Mahalapbutr Watcharin Loilome |
2021 |
CANCER & METABOLISM 1.0 (9.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 8. | Investigating the microbiota of fermented fish products (Pla-ra) from different communities of northeastern Thailand | Rutchanee Rodpai Oranuch Sanpool Tongjit Thanchomnang Arporn Wangwiwatsin Lakkhana Sadaow Weeraya Phupiewkham Patcharaporn Boonroumkaew Pewpan M. Intapan Wanchai Maleewong |
2021 |
PLOS ONE 1.0 (16.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 9. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Yingpinyapat Kittirat Jutarop Phetcharaburanin Bundit Promraksa Thanaporn Kulthawatsiri Arporn Wangwiwatsin Poramate Klanrit Sakkarn Sangkhamanon Apiwat Jarearnrat Suyanee Thongchot Panupong Mahalapbutr Watcharin Loilome Hideyuki Saya Nisana Namwat |
2021 |
FRONTIERS IN PUBLIC HEALTH (9.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 10. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models | Malinee Thanee Sureerat Padthaisong Manida Suksawat Hasaya Dokduang Jutarop Phetcharaburanin Poramate Klanrit Attapol Titapun Nisana Namwat Arporn Wangwiwatsin Prakasit Sa-ngiamwibool Narong Khuntikeo Hideyuki Saya Watcharin Loilome |
2021 |
CANCER & METABOLISM 1.0 (9.0), pp. |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 11. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Jittima Tomacha Hasaya Dokduang Sureerat Padthaisong Nisana Namwat Poramate Klanrit Jutarop Phetcharaburanin Arporn Wangwiwatsin Tueanjit Khampitak Supinda Koonmee Attapol Titapun Apiwat Jarearnrat Narong Khuntikeo Watcharin Loilome |
2021 |
FRONTIERS IN PHARMACOLOGY (12.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title |
|---|
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
|---|